MSC2490484A

DNA-dependent protein kinase inhibitor · EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSC2490484A, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy [Phase 1]

See pricing